This bill will strengthen and improve the National Cervical Screening Programme, a programme that protects the health of women throughout our country. It will enable the programme to take advantage of modern information technology. The new rules are needed because Part 4A of the Health Act did not anticipate the information technology that is available now. The bill also paves the way for the screening programme to move to human papillomavirus (HPV) testing, which causes 99 percent of cervical cancer. As we have discussed earlier today, in Budget '21 we included investment of up to $53 million to complete the design and implementation of human papillomavirus screening. The new test will replace the current smear test for the 1.4 million eligible women aged 25 to 69 years old. It is a simple and quick swab that women in the future will be able to do themselves and does not require an invasive speculum exam. We anticipate, based on trials that have occurred here in New Zealand, that this will greatly reduce the barriers to getting screened.